The trademark application TUMOUR DEFENCE BREAKER was filed by HELIX IMMUNO-ONCOLOGY SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ, a corporation established under the laws of the Republic of Poland (the "Applicant"). Application refused.
The application was filed in Polish (English was selected as the second language).
Deletion of the representative of the trademark registration was recorded on February 12, 2017. Appointment and Replacement of representative of the trademark registration was recorded on March 13, 2017. Change of name and address of the trademark registration was recorded on April 11, 2017. Change of name and professional address of the trademark registration was recorded on June 20, 2017.
The Appeal with reference B R1545/2017-5 was Application rejected according to Article 7(1)(c) EUTMR with decision issued on September 28, 2017 by the EUIPO. The Refusal with reference B 015962723 was Rejected according to Article 7(1)(b) EUTMR with decision issued on May 15, 2017 by the EUIPO.
Goods And Services
The mark was filed in class 1 with Chemical substances, chemical materials and chemical preparations, and natural elements and Chemical compositions and materials for use in science..
The mark was filed in class 5 with following description of goods:
Medical and veterinary preparations and articles
Pharmaceuticals and natural remedies
Diagnostic preparations
Enzymes for medical purposes
Enzyme preparations for medical purposes
Biochemical preparations for medical use
Chemical preparations for medical purposes
Medicinal healthcare preparations.
The mark was filed in class 42 with following description of goods:
Medical and pharmacological research services
Consultancy pertaining to pharmacology
Consultancy relating to research and development in the field of therapeutics
Consultancy relating to laboratory testing
Clinical research
Research and development for the pharmaceutical industry
Research on the subject of pharmaceuticals
Biological research, clinical research and medical research
Scientific research for medical purposes in the area of cancerous diseases
Pharmaceutical products development
Development of pharmaceutical preparations and medicines
Conducting clinical trials for pharmaceutical products
Research and development in the pharmaceutical and biotechnology fields
Testing of pharmaceuticals
Clinical trials.
The mark was filed in class 44 with Pharmaceutical services and Medical services..